Clinical Trial Update: A Study to Evaluate Biomarkers in Chronic Obstructive Pulmonary Disease

View source ↗

Summary

The document reports that MedImmune LLC's clinical study to evaluate biomarkers in chronic obstructive pulmonary disease has terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: MedImmune LLC | Conditions: Chronic Obstructive Pulmonary Disease | Status: TERMINATED